Author

J. Reynisson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

E. Cooper· 1 shared E. Leung· 1 shared J. Jose· 1 shared M. Tercel· 1 shared P. J. Choi· 1 shared P. Tomek· 1 shared T. I. H. Park· 1 shared W. A. Denny· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. Cooper

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Conjugation of palbociclib with MHI-148 has an increased cytotoxic effect for breast cancer cells and an altered mechanism of action

E. Leung, P. Tomek, M. Tercel, J. Reynisson, T. I. H. Park, E. Cooper, W. A. Denny, P. J. Choi, J. Jose

This study conjugates palbociclib with MHI-148, showing increased cytotoxicity in breast cancer cells but a different mechanism of action compared to palbociclib alone.

bioRxiv · Nov 2, 2021 · PreprintCancer Biology